Nuclear medicine can help avoid unnecessary angioplasty

Thursday, April 13, 2017

Mumbai: In an interview with DNA, Dr G N Mahapatra, head of department of non-invasive cardiology at Seven Hills Hospital, Mumbai explains how nuclear medicine can help avoid unnecessary angioplasty and why many cardiologists don’t prescribe it.

Dr G N Mahapatra

Dr G N Mahapatra

Dr Mahapatra says: “Several patients who undergo angioplasty return with the symptoms. That’s because the patient did not need an angioplasty. After the first heart attack, certain heart muscles die and cannot be recovered. But cosmetic angioplasties are still carried out throughout India.”

According to Dr Mahapatra, “Angiography can only detect blockages, and often gives false positives in female patients. Nuclear medicine can also show if the heart muscle is already dead and helps avoid unnecessary surgeries. The tests are also painless and non-invasive, and it costs about a third of an angiogram.”

Nuclear medicine relies on radioactive isotopes to assess the blood flow in the heart. A technician inserts radioactive isotopes such as thallium intravenously. The isotope marks the blood flow and a gamma camera maps it. The test includes readings in active and resting positions.

“Besides thallium, we now also use technetium, the lightest element of radioactive isotopes. It does not leave behind any radiation and is excreted from the body in six hours. In Europe and USA, most cardiologists compliment their practice with nuclear medicine,” says Dr Mahapatra.

“Cardiologists must offer a conclusive test such as the thallium test before going ahead with surgery. Unfortunately, some cardiologists say creating more awareness about this would affect business,” adds Dr Mahapatra.

Categories: Diagnostics, NEWS

Tags: , , , , , , ,

  More from Diagnostics

Nuclear medicine can help avoid unnecessary angioplasty

Faulty gene identified as cause of obesity in world’s heaviest woman

Dr Lal PathLabs to open central labs in Kolkata, Lucknow

New blood test assists oncologists with tumour treatment optimization

BD launches diagnostic instrument for rapid identification of bacteria and detection of antimicrobial resistance

Respiratory diagnostics market expected to reach $7.45 billion by 2021

Comments »

No comments yet.

Name (required)
E-mail (required - never shown publicly)
Your Comment (smaller size | larger size)
You may use <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> in your comment.